Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

1 firefighter in cardiac arrest, 2 injured in Bucheon factory fire

One firefighter went into cardiac arrest and two others were injured Friday as they responded to a fire at a factory in Bucheon, just west of Seoul, officials said. The fire broke out at the four-story metal parts coating factory at 8:38 a.m., prompting authorities to dispatch 80 firefighters to combat the blaze. Two firefighters were rushed to hospitals after being isolated as they responded to…

1 firefighter in cardiac arrest, 2 injured in Bucheon factory fire

A firefighter suffered cardiac arrest and two others were injured while responding to a fire at a factory in Bucheon, South Korea, on Friday morning, officials reported. The blaze erupted at a four-story metal parts coating facility at 8:38 a.m. local time, prompting authorities to deploy 80 firefighters to tackle the inferno. Two of the firefighters were hospitalized after being isolated upon arrival at the scene, with one of them experiencing cardiac arrest.

The third firefighter suffered minor injuries in the incident. Additionally, two officials from the factory sustained injuries as well. Fire authorities managed to contain the primary blaze by 10:22 a.m., and they intend to investigate the exact cause of the fire once it has been fully extinguished. Upon learning about the fire, President Lee Jae Myung called for all-out efforts to extinguish the flames and rescue those in peril, as stated by presidential spokesperson Kang Yu-jung.

The president emphasized the need for a thorough response to prevent further damage, citing the presence of inflammable substances within the factory, and stressed the importance of taking extra precautions to safeguard the safety of the firefighters on the ground.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at koreatimes.co.kr →

More in Health & Medicine

LigaChem Doses First Patient in Global Trial of Cancer-Targeting ADC

LigaChem Biosciences has begun global clinical development of its proprietary Claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC) candidate, LCB02A. The company announced on Oct.

  • LigaChem begins global Phase 1/2 trial for CLDN18.2-targeting ADC LCB02A on October 15
  • Study involves up to 191 patients with advanced solid tumors expressing CLDN18.2
  • ADC uses LigaChem's ConjuAll platform with exatecan cytotoxic payload

More from Friday 16 October →